2007
DOI: 10.1111/j.1365-2516.2007.01596.x
|View full text |Cite
|
Sign up to set email alerts
|

Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
9
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 5 publications
1
9
0
Order By: Relevance
“…In their 1993 survey, Fressinaud and Meyer [3] did not identify angiodysplasia in any patients with type 1 VWD whilst we found GI bleeding in nine of 48 patients which was confirmed to be due to angiodysplasia in four individuals. Angiodysplasia in type 1 VWD was also reported in three patients from Italy that are not included in our cohort [10]. In view of the demonstration that VWF has antiangiogenic properties and likely to be aetiological in the development of angiodysplasia, there is no reason why it would not be seen in type 1 disease, and is consistent with the more frequent angiodysplasia in patients with type 3 VWD of 4.5% [2,3,7].…”
Section: Discussionsupporting
confidence: 76%
“…In their 1993 survey, Fressinaud and Meyer [3] did not identify angiodysplasia in any patients with type 1 VWD whilst we found GI bleeding in nine of 48 patients which was confirmed to be due to angiodysplasia in four individuals. Angiodysplasia in type 1 VWD was also reported in three patients from Italy that are not included in our cohort [10]. In view of the demonstration that VWF has antiangiogenic properties and likely to be aetiological in the development of angiodysplasia, there is no reason why it would not be seen in type 1 disease, and is consistent with the more frequent angiodysplasia in patients with type 3 VWD of 4.5% [2,3,7].…”
Section: Discussionsupporting
confidence: 76%
“…For the same reasons surgical resection is not useful, even when the actually bleeding area is identified by endoscopic videocapsules (Fig ). The somastatin analogue octreotide, the antifibrinolytic amino acid tranexamic acid and desmopressin are usually of little help to stop bleeding refractory to replacement therapy (Chey et al , ; Bowers et al , ; Siragusa et al , ). When aneamia is severe (below 90 g/l), red blood cell transfusion is needed, whereas iron administration is helpful only for less severe chronic anemia.…”
Section: Angiodysplasia and Congenital Von Willebrand Diseasementioning
confidence: 99%
“…Women with VWD have an increased incidence of endometriosis, uterine fibroids and menorrhaghia which, in type 3 VWD, almost always causes iron deficiency and requires long‐term oral contraceptive use. Mucosal vascular abnormalities are also associated with VWD [110,111].…”
mentioning
confidence: 99%